Stockscreener 앱 받기
37.46
0.48%
-0.18
시간 외 거래:
37.46
Surmodics Inc 주식(SRDX)의 최신 뉴스
Visualizing Surmodics Inc. stock with heatmapsQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Intraday pattern recognizer results for Surmodics Inc.2025 Top Gainers & Fast Gaining Stock Reports - Newser
Will Surmodics Inc. rebound enough to break evenJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Using fundamentals and technicals on Surmodics Inc.Portfolio Growth Summary & Weekly Top Gainers Alerts - Newser
Using data filters to optimize entry into Surmodics Inc.2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Understanding Surmodics Inc.’s price movementExit Point & Daily Technical Forecast Reports - Newser
Tools to assess Surmodics Inc.’s risk profileJuly 2025 Pullbacks & Stock Timing and Entry Methods - Newser
Will Surmodics Inc. price bounce be sustainableLayoff News & Daily Growth Stock Investment Tips - Newser
Does Surmodics Inc. qualify in momentum factor screeningMarket Trend Review & Risk Managed Investment Strategies - Newser
Detecting price anomalies in Surmodics Inc. with AIJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Is Surmodics Inc. trending in predictive chart modelsWeekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
Is a relief rally coming for Surmodics Inc. holders2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
What makes Surmodics Inc. stock price move sharplyShare Buyback & Long-Term Growth Plans - thegnnews.com
Does Surmodics Inc. show high probability of reboundWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Why Surmodics Inc. stock attracts strong analyst attentionQuarterly Market Summary & High Conviction Buy Zone Alerts - sundaytimes.kr
How Efficient Is Surmodics Inc. at Controlling Operating CostsGap Up & Safe Capital Allocation Plans - Newser
Surmodics Reports Mixed Financial Results, Highlighting Profit Growth and Sales Challenges in June 2025 - MarketsMojo
Is this a good reentry point in Surmodics Inc.Portfolio Update Report & Community Trade Idea Sharing Platform - Newser
Using Bollinger Bands to evaluate Surmodics Inc.2025 Price Action Summary & Reliable Entry Point Trade Alerts - Newser
What Fibonacci levels say about Surmodics Inc. rebound2025 Key Lessons & Consistent Growth Equity Picks - Newser
Is Surmodics Inc. stock a growth or value playROI Focused Watchlist with Trade Confidence - Newser
FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix - Law360
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts - TradingView
GTCR-Surmodics divestiture to be evaluated by FTC by Aug. 15, US court told - MLex
What is the target price for Surmodics Inc. stockPrice Volume Breakout Screener - newsyoung.net
Analyzing drawdowns of Surmodics Inc. with statistical toolsSecure Asset Flow and Trend Pattern Analysis - Newser
Is Surmodics Inc. exposed to political riskQuality Dividend Stock Finder - newsyoung.net
Surmodics (SRDX) Maintains Market Perform Rating by Barrington Research - AInvest
SurModics Maintains Hold Rating Amid Mixed Financial Performance and Ongoing Litigation - AInvest
Surmodics revenue down 3% to USD 29.6M in Q3 2025 - Medical Buyer
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - NewsBreak: Local News & Alerts
Surmodics 2025 Q3 Earnings Loss Narrows 29.6% - AInvest
SurModics' Strong Financials Offset by Acquisition Uncertainty - AInvest
SurModics: Fiscal Q3 Earnings Snapshot - Connecticut Post
Surmodics Lifts Guidance Despite Dips In Device Revenue - Finimize
GTCR, Surmodics file opposition to US FTC's motion for preliminary injunction - MLex
UPDATE: FTC request for GTCR/Surmodics divestiture docs denied - Global Competition Review
FTC seeks GTCR/Surmodics divestiture docs - Global Competition Review
SurModics earnings beat by $0.25, revenue topped estimates - Investing.com Canada
SurModics (SRDX) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
SURMODICS INC SEC 10-Q Report - TradingView
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - Placera.se
Surmodics raises FY25 EPS view to (35c)-(20c) from (62c)-(42c) - TipRanks
SURMODICS Earnings Results: $SRDX Reports Quarterly Earnings - Quiver Quantitative
Medical device maker Surmodics's Q3 revenue dips 3%, FY guidance raised - MarketScreener
Surmodics (SRDX) Q3 EPS Turns Positive - AOL.com
Surmodics Reports Third Quarter Fiscal 2025 Financial Results - TradingView
What data driven models say about Surmodics Inc.’s futureDaily Trade Monitor with Pattern Alerts - Newser
Is Surmodics Inc. meeting your algorithmic filter criteriaAsset Growth Pattern and Return Summary - Newser
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - BioSpace
Press Release: Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - 富途牛牛
1.74%
0.24%
자본화:
|
볼륨(24시간):